| NRGEX | UMBHX | NRGEX / UMBHX | |
| Total Expense Ratio | 0.03 | 0.90 | 3% |
| Annual Report Gross Expense Ratio | 0.69 | 0.90 | 77% |
| Fund Existence | 4 years | 39 years | - |
| Gain YTD | -4.609 | 7.944 | -58% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 10000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 8.43B | 236M | 3,570% |
| Annual Yield % from dividends | 0.55 | 0.00 | - |
| Returns for 1 year | -13.79 | -6.72 | 205% |
| Returns for 3 years | 0.06 | 20.15 | 0% |
| Returns for 5 years | N/A | -5.24 | - |
| Returns for 10 years | N/A | 26.36 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CGCYX | 49.54 | 0.01 | +0.02% |
| Columbia Greater China Inst3 | |||
| PRHSX | 90.91 | -0.46 | -0.50% |
| T. Rowe Price Health Sciences | |||
| PCMVX | 16.11 | -0.19 | -1.17% |
| Principal MidCap Value I A | |||
| DEOPX | 23.13 | -0.43 | -1.83% |
| Davenport Equity Opportunities | |||
| MOINX | 25.74 | -0.58 | -2.20% |
| NYLI WMC Small Companies Investor Class | |||